Dean Wenham

Dean Wenham has a diverse work experience in various leadership roles. In August 2005, they became the President and CEO of InSymbiosis, where they served until June 2019. In August 2005, they also became the Chief Executive Officer of Aronnax Inc and held the position until 2016. From February 2016 until present, Dean Wenham has been serving as the CEO and Partner at InSynchrony Ventures. Additionally, in November 2019, they co-founded Ocean Diagnostics Inc and became a Director with the company. Dean then transitioned to the role of CEO until January 2023.

Dean Wenham earned their Doctor of Philosophy (Ph.D.) degree in Pharmacology from UCL, completing the program between 1991 and 1994.